MedPath

Multicenter trial of elective revascularization in patients with diabetes mellitus and mild anginal complaints.

Suspended
Conditions
Stable and mild complaints of coronary artery disease in patients with diabetes mellitus type 2.
Registration Number
NL-OMON20816
Lead Sponsor
* The Netherlands Heart Foundation (NHS)* The Netherlands Organisation for Health Research and Development (ZonMw)
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
800
Inclusion Criteria

1. A history of diabetes mellitus type 2, evidenced by either of the following:

Exclusion Criteria

1. Younger than 30 years of age;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
One or more of the following complications within the duration of follow-up:<br /><br>a. All-cause mortality;<br /><br>b. Non-fatal myocardial infarction;<br /><br>c. Hospital admission for acute coronary syndrome.
Secondary Outcome Measures
NameTimeMethod
1. Each of the above components of the composite endpoint;<br /><br>2. Cardiac mortality;<br /><br>3. Newly developed diabetic morbidity (diabetic retinopathy, diabetic nephropathy, and changes in blood glucose regulation) documented in routine clinical practice;<br /><br>4. Functional status at one and two years;<br /><br>5. Quality of life.
© Copyright 2025. All Rights Reserved by MedPath